H S Sader - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H S Sader

Showing results (41-50 of 100) with videos related to

Pageof 10

Sort By:

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 11, 2004

Inter-hospital dissemination of glycopeptide-resistant Enterococcus faecalis in BrazilJ C R Cordeiro, S Silbert, A O Reis, et al.

Journal of Chemotherapy (Florence, Italy)|December 6, 2005

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004)P R Rhomberg, T R Fritsche, H S Sader, et al.

Journal of Chemotherapy (Florence, Italy)|December 6, 2005

Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.

Journal of Chemotherapy (Florence, Italy)|March 18, 2008

Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centersH S Sader, A A Watters, T R Fritsche, et al.

Journal of Global Antimicrobial Resistance|July 24, 2017

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.

International Journal of Antimicrobial Agents|October 11, 2017

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.

Diagnostic Microbiology and Infectious Disease|March 24, 2018

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014M A Pfaller, H S Sader, R K Flamm, et al.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2004

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance ProgramM Castanheira, A C Gales, R E Mendes, et al.

Diagnostic Microbiology and Infectious Disease|July 14, 1999

Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptidesL Del' Alamo, R F Cereda, I Tosin, et al.

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 4, 2000

In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactamsR K Roland, R E Mendes, S Silbert, et al.

Pageof 10

Search research articles

Showing results (41-50 of 100) with videos related to

Sort By:

Pageof 10

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 11, 2004

Inter-hospital dissemination of glycopeptide-resistant Enterococcus faecalis in BrazilJ C R Cordeiro, S Silbert, A O Reis, et al.

Journal of Chemotherapy (Florence, Italy)|December 6, 2005

Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.

Journal of Chemotherapy (Florence, Italy)|March 18, 2008

Journal of Global Antimicrobial Resistance|July 24, 2017

International Journal of Antimicrobial Agents|October 11, 2017

Diagnostic Microbiology and Infectious Disease|March 24, 2018

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2004

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance ProgramM Castanheira, A C Gales, R E Mendes, et al.

Diagnostic Microbiology and Infectious Disease|July 14, 1999

Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptidesL Del' Alamo, R F Cereda, I Tosin, et al.

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 4, 2000

In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactamsR K Roland, R E Mendes, S Silbert, et al.

Pageof 10